Wasatch Advisors Inc Dyne Therapeutics, Inc. Transaction History
Wasatch Advisors Inc
- $17.6 Billion
- Q1 2025
A detailed history of Wasatch Advisors Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 511,048 shares of DYN stock, worth $5.7 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
511,048
Previous 320,626
59.39%
Holding current value
$5.7 Million
Previous $7.55 Million
29.23%
% of portfolio
0.03%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding DYN
# of Institutions
217Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$116 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$108 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$102 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$82.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$82.4 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $578M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...